For the quarter ending 2026-03-31, MIST has $193,734K in assets. $157,685K in debts. $71,317K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 71,317 | 46,685 | 42,499 | |
| Short-term investments | 112,899 | 35,900 | 918 | |
| Accounts receivable, net | 1,605 | - | - | |
| License receivable | 1,546 | - | - | |
| Research and development tax credits receivable | 425 | 808 | 1,079 | |
| Prepaid expenses | 1,210 | 2,577 | 748 | |
| Inventory, net | 1,826 | - | - | |
| Other receivables | 1,425 | 700 | 924 | |
| Total current assets | 192,253 | 86,670 | 46,168 | |
| Operating lease right-of-use assets | 981 | 944 | 1,090 | |
| Property and equipment, net | 500 | 136 | 159 | |
| Total assets | 193,734 | 87,750 | 47,417 | |
| Accounts payable | 10,023 | - | - | |
| Accounts payable and accrued liabilities | - | 10,041 | 8,768 | |
| Accrued liabilities | 9,803 | - | - | |
| Operating lease liabilities | 659 | 483 | 515 | |
| Deferred revenue | 416 | - | - | |
| Other current liabilities | 43 | - | - | |
| Total current liabilities | 20,944 | 10,524 | 9,283 | |
| Operating lease liabilities, net of current portion | 366 | 519 | 641 | |
| Senior secured convertible notes | 58,192 | 56,206 | 55,238 | |
| Royalty financing obligation, long-term | 78,111 | - | - | |
| Other long-term liabilities | 72 | - | - | |
| Total liabilities | 157,685 | 67,249 | 65,162 | |
| Common shares, no par value, unlimited shares authorized, 117,794,417 shares issued and outstanding as of march 31, 2026, 106,236,344 shares issued and outstanding as of december 31, 2025 | 373,702 | 311,776 | 288,263 | |
| Pre-funded warrants - 16,412,925 issued and outstanding as of march 31, 2026 and 16,412,925 as of december 31, 2025 | 55,649 | 55,649 | 53,076 | |
| Additional paid-in capital | 63,367 | 66,270 | 42,188 | |
| Accumulated deficit | -456,669 | -413,194 | -401,272 | |
| Total shareholders' equity | 36,049 | 20,501 | -17,745 | |
| Total liabilities and shareholders' equity | 193,734 | 87,750 | 47,417 | |
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)